Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Oncologix Tech Inc. (OCLG)
Lafayette, LA, US
Oncologix Tech, Inc., a diversified medical holding company, provides health care services in the United States. It offers personal home care services, including daily living assistance, companionship, and homemaker services, as well as Alzheimer's care, home care resource planning, and medical care coordination services. The company also manufactures, markets, and distributes medical technologies and products for skilled nursing facilities, acute and critical care facilities, assisted living facilities, hospitals and medical institutions, federal agencies, home medical care industry, respiratory and therapy- physical/occupational therapy centers. In addition, it distributes and sells home medical equipment for sleep and respiratory therapies; supplies and services durable medical equipment to treat obstructive Sleep Apnea; C-PAP and BiPAP oxygen equipment, a large selection of mask interfaces; and offers personalized treatment plans, as well as monitoring and support services. The company was formerly known as BestNet Communications Corp. and changed its name to Oncologix Tech, Inc. in January 2007. Oncologix Tech, Inc. was founded in 1995 and is based in Lafayette, Louisiana.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.00% | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% | -86.67% | -95.65% | -75.00% | -99.52% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Financial - Conglomerates: +32.7%-29.0% Q4'22: -100.0% (vs Q1'17)
-
EPS growth Financial - Conglomerates: +16.6%-23.1% Q4'22: +98.6% (vs Q1'17)
-
FCF margin FCF growth · Financial - Conglomerates: +2.3%-10.2%
-
EBIT margin Financial - Conglomerates: +36.2%-39.5%
-
ROIC Financial - Conglomerates: +2.2%—
-
Share dilution Financial - Conglomerates: +0.0%+2.3% Q4'22: +125.7% (vs Q1'17)
-
Debt / EBITDA Net debt/EBITDA · Financial - Conglomerates: 2.57×-4.64× Q4'22: -0.31× (vs Q1'17)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2013-02-08 | SILVERMAN ANTHONY | Director / Officer | A-Award | A | Common Stock | 1,024,164 | 0.01 | 10.2K | 7,243,059 | — | ↗ |
| 2012-01-26 | SILVERMAN ANTHONY | Director / Officer | D-Return | A | Convertible Note | 250,000 | 0.04 | 10.0K | 253,500 | — | ↗ |
| 2011-12-26 | SILVERMAN ANTHONY | Director / Officer | J-Other | A | Convertible Note | 250,000 | 0.04 | 10.0K | 503,500 | — | ↗ |
| 2011-10-06 | SILVERMAN ANTHONY | Director / Officer | A-Award | A | Common Stock | 1,778,193 | 0.04 | 71.1K | 6,220,906 | — | ↗ |
| 2011-01-26 | SILVERMAN ANTHONY | Director / Officer / 10% Owner | D-Return | D | Stock Options (Common Stock) | 20,000 | 0.17 | 3.4K | 50,000 | — | ↗ |
| 2009-12-30 | SILVERMAN ANTHONY | Director / Officer / 10% Owner | G-Gift | D | Common Stock | 4,759,452 | 0.05 | 238.0K | 17,770,850 | — | ↗ |
| 2009-07-27 | SILVERMAN ANTHONY | Director / Officer / 10% Owner | C-Conversion | D | Convertible Note | 402,100 | 0.05 | 20.1K | 70,000 | — | ↗ |
| 2008-12-31 | SILVERMAN ANTHONY | Director / Officer / 10% Owner | E-ExpireShort | D | Warrants (right to buy) | 40,000 | 0.03 | 1.1K | 427,100 | — | ↗ |
| 2008-10-08 | SILVERMAN ANTHONY | Director / 10% Owner | A-Award | A | Common Stock | 1,500,000 | 0.05 | 75.0K | 24,984,852 | — | ↗ |
| 2008-08-12 | SILVERMAN ANTHONY | Director / 10% Owner | G-Gift | D | Common Stock | 500,000 | 0.05 | 25.0K | 23,484,852 | — | ↗ |
| 2008-08-05 | SILVERMAN ANTHONY | Director / 10% Owner | A-Award | A | Common Stock | 1,500,000 | 0.01 | 15.0K | 23,984,852 | — | ↗ |
| 2008-06-16 | SCHLOZ STANLEY | Director | A-Award | A | Common Stock | 1,000,000 | 0.00 | — | 1,711,992 | — | ↗ |
| 2008-06-11 | SILVERMAN ANTHONY | Director / 10% Owner | A-Award | A | Convertible Note | 402,100 | 0.15 | 60.3K | 512,100 | — | ↗ |
| 2008-06-05 | SILVERMAN ANTHONY | Director | A-Award | A | Common Stock | 4,759,452 | 0.05 | 238.0K | 9,375,852 | — | ↗ |
| 2007-11-30 | SCHLOZ STANLEY | Director | D-Return | A | Convertible Note | 500,000 | 0.20 | 100.0K | 435,000 | — | ↗ |
| 2007-09-04 | SCHLOZ STANLEY | Director | A-Award | A | Convertible Note | 750,000 | 0.20 | 150.0K | 935,000 | — | ↗ |
| 2007-02-07 | SCHLOZ STANLEY | Director / Officer | S-Sale | D | Connom Stock | 15,000 | 0.48 | 7.2K | 711,992 | — | ↗ |
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Michael A. Kramarz | Chairman of the Board, Chief Executive Officer, Chief Financial Officer & Secretary | 80.2K | male |
| Harold Halman | Chief Operating Officer & Director | — | male |
| Nikole Jessie | Director of Marketing & Public Relations | — | female |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for OCLG
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
